Swedish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Mendus

Market Cap: SEK 332.3m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

Swedish Orphan Biovitrum

Market Cap: SEK 96.2b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Biovica International

Market Cap: SEK 167.4m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.

Genetic Analysis

Market Cap: NOK 60.8m

A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

Moberg Pharma

Market Cap: SEK 400.0m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Hamlet BioPharma

Market Cap: SEK 746.3m

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

Xspray Pharma

Market Cap: SEK 2.5b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Nidhogg Resources Holding

Market Cap: SEK 13.8m

Operates in the natural resources sector primarily in Sweden.

Curasight

Market Cap: DKK 218.3m

Develops therapeutic and diagnostic solutions for the treatment of cancer.

Sprint Bioscience

Market Cap: SEK 59.1m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Double Bond Pharmaceutical International

Market Cap: SEK 12.9m

A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.

LIDDS

Market Cap: SEK 9.5m

A drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden.

Novakand Pharma

Market Cap: SEK 31.0m

Develops drugs for inflammatory diseases and cancer in Sweden and internationally.

Lipigon Pharmaceuticals

Market Cap: SEK 85.4m

Develops drugs for lipid related diseases in Sweden.

Corline Biomedical

Market Cap: SEK 361.2m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Attana

Market Cap: SEK 32.6m

Provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia.

AcouSort

Market Cap: SEK 67.5m

A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.

Xbrane Biopharma

Market Cap: SEK 626.2m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Vitrolife

Market Cap: SEK 17.4b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Spago Nanomedical

Market Cap: SEK 69.5m

A clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden.

NextCell Pharma

Market Cap: SEK 108.1m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

SynAct Pharma

Market Cap: SEK 1.1b

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Enzymatica

Market Cap: SEK 577.7m

A life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract.

Coegin Pharma

Market Cap: SEK 206.5m

A biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden.

Prostatype Genomics

Market Cap: SEK 21.4m

Prostatype Genomics AB manufactures, markets, and sells prognostic gene tests.

Active Biotech

Market Cap: SEK 204.0m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

PExA

Market Cap: SEK 13.4m

Develops and commercializes diagnostic products in various respiratory diseases.

BICO Group

Market Cap: SEK 1.5b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Alzinova

Market Cap: SEK 127.9m

A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

Level Bio

Market Cap: SEK 22.2m

Manufactures and distributes cutting-edge solutions in the Nordic region and internationally.

ExpreS2ion Biotech Holding

Market Cap: SEK 45.2m

A biotechnology company, develops vaccines and biologics products to address critical unmet medical needs in the Nordics and internationally.

ODI Pharma

Market Cap: SEK 27.3m

A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.

Diagonal Bio

Market Cap: SEK 13.1m

Operates as a biotechnology company in Sweden.

Guard Therapeutics International

Market Cap: SEK 453.8m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.